Contineum Therapeutics
CTNM
#7708
Rank
โ‚ฌ0.30 B
Marketcap
10,52ย โ‚ฌ
Share price
10.96%
Change (1 day)
-23.33%
Change (1 year)

Revenue for Contineum Therapeutics (CTNM)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚ฌ45.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Contineum Therapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 โ‚ฌ45.23 M